Recent CYAD News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 05/16/2023 10:03:23 AM
- Celyad Oncology Announces Receipt of Nasdaq Delisting Notice • Business Wire • 05/15/2023 08:01:00 PM
- Celyad Oncology announces receipt of Nasdaq delisting notice • GlobeNewswire Inc. • 05/15/2023 08:01:00 PM
- Celyad Oncology annonce la réception d’un avis de radiation du Nasdaq • Business Wire • 05/15/2023 08:01:00 PM
- Celyad Oncology annonce son intention de radier les American Depositary Shares de la Société du Nasdaq • Business Wire • 05/05/2023 05:44:00 AM
- Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq • Business Wire • 05/05/2023 05:44:00 AM
- Celyad Oncology Reports First Quarter 2023 Financial Results and Recent Business Highlights • Business Wire • 05/05/2023 05:42:00 AM
- Celyad Oncology publie ses résultats financiers pour le premier trimestre de 2023 ainsi que ses récentes avancées • Business Wire • 05/05/2023 05:42:00 AM
- Celyad Oncology reports first quarter 2023 financial results and recent business highlights • GlobeNewswire Inc. • 05/05/2023 05:00:00 AM
- Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq • GlobeNewswire Inc. • 05/05/2023 05:00:00 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 04/24/2023 08:14:45 PM
- Celyad Oncology annonce la réception d’une notification initiale du Nasdaq sur le prix de l’ADS • Business Wire • 04/24/2023 08:01:00 PM
- Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid Price • Business Wire • 04/24/2023 08:01:00 PM
- Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price • GlobeNewswire Inc. • 04/24/2023 08:01:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 04/05/2023 11:46:42 AM
- Celyad Oncology announces receipt of Nasdaq notice • GlobeNewswire Inc. • 04/04/2023 08:01:00 PM
- Celyad Oncology announces receipt of Nasdaq notice • Business Wire • 04/04/2023 08:00:00 PM
- Celyad Oncology annonce la réception d’une notification du Nasdaq • Business Wire • 04/04/2023 08:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 04/04/2023 11:46:40 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 03/24/2023 11:46:23 AM
- Celyad Oncology Appoints Georges Rawadi as Its New CEO • Business Wire • 03/24/2023 06:00:00 AM
- Celyad Oncology nomme Georges Rawadi comme nouveau CEO • Business Wire • 03/24/2023 06:00:00 AM
- Celyad Oncology appoints Georges Rawadi as its new CEO • GlobeNewswire Inc. • 03/24/2023 06:00:00 AM
- Celyad Oncology Reports Full Year 2022 Financial Results and Recent Business Highlights • Business Wire • 03/23/2023 09:01:00 PM
- Celyad Oncology publie ses résultats financiers pour l'année 2022 ainsi que les récents évènements marquants • Business Wire • 03/23/2023 09:01:00 PM
CGrowth Capital Consolidates Lithium Tenement Portfolio in Tanzania Amid Renewed Mining Confidence • CGRA • May 25, 2023 11:05 AM
Interactive Strength Inc. d/b/a FORME Launches European Expansion Plan by Focusing on Strategic Partnership with SIGNA Sports United • TRNR • May 24, 2023 10:14 AM
Nextech3D.ai Game-Changing Generative-AI CAD 3D Design Studio Toggle3D.ai Primed For $7 Million June IPO • NTAR • May 24, 2023 10:00 AM
Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • KAYS • May 24, 2023 9:48 AM
ILUS Confirms Its First Quarter of 2023 Results • ILUS • May 23, 2023 9:34 AM
SKYX Set to Join Russell 2000® and Russell 3000® Indexes • SKYX • May 23, 2023 8:56 AM